Transient receptor potential channel

Results: 42



#Item
1The Doctoral Program ION CHANNELS AND TRANSPORTERS AS MOLECULAR DRUG TARGETS („MolTag“) is pleased to invite you to the following lecture:

The Doctoral Program ION CHANNELS AND TRANSPORTERS AS MOLECULAR DRUG TARGETS („MolTag“) is pleased to invite you to the following lecture: "The two faces of TRPC proteins - understanding their function in immune cell

Add to Reading List

Source URL: moltag.univie.ac.at

Language: English - Date: 2016-05-09 10:49:35
2B’SYS GmbH  CHO TRPV1 Cell Line Specification Sheet © B’SYS GmbH

B’SYS GmbH CHO TRPV1 Cell Line Specification Sheet © B’SYS GmbH

Add to Reading List

Source URL: www.bsys.ch

Language: English - Date: 2016-05-11 07:51:55
3Microsoft Word - Session_05_Pain and Nociception.doc

Microsoft Word - Session_05_Pain and Nociception.doc

Add to Reading List

Source URL: www.sbfte.org.br

Language: English - Date: 2015-04-07 16:02:11
4Microsoft Word - setor_03_Psychopharmacology.docx

Microsoft Word - setor_03_Psychopharmacology.docx

Add to Reading List

Source URL: sbfte.org.br

Language: English - Date: 2015-04-06 13:15:11
5Released lipids regulate Transient Receptor Potential Channel (TRP)-dependent oral cancer pain

Released lipids regulate Transient Receptor Potential Channel (TRP)-dependent oral cancer pain

Add to Reading List

Source URL: www.molecularpain.com

Language: English
    6Finnish Pharmacological Society, Annual Meeting 2014 TampereMonday – 10.15 Welcome coffee 10.15 – 12.20 Session 1: Signaling cascades as drug targets in inflammation Chair: Professor Raimo Tuo

    Finnish Pharmacological Society, Annual Meeting 2014 TampereMonday – 10.15 Welcome coffee 10.15 – 12.20 Session 1: Signaling cascades as drug targets in inflammation Chair: Professor Raimo Tuo

    Add to Reading List

    Source URL: www.sfy.fi

    Language: English - Date: 2014-03-04 04:38:58
    7Hydra Biosciences Reaps $22.2M Series D Brian Gormley January 16, 2009 VentureWire New Money Hydra Biosciences Inc., which seeks to treat pain, pulmonary diseases and other

    Hydra Biosciences Reaps $22.2M Series D Brian Gormley January 16, 2009 VentureWire New Money Hydra Biosciences Inc., which seeks to treat pain, pulmonary diseases and other

    Add to Reading List

    Source URL: www.hydrabiosciences.com

    Language: English - Date: 2009-01-21 16:07:02
    8TRPA1 mediates formalin-induced pain Colleen R. McNamara*, Josh Mandel-Brehm*, Diana M. Bautista†, Jan Siemens†, Kari L. Deranian*, Michael Zhao*, Neil J. Hayward*, Jayhong A. Chong*, David Julius†‡, Magdalene M.

    TRPA1 mediates formalin-induced pain Colleen R. McNamara*, Josh Mandel-Brehm*, Diana M. Bautista†, Jan Siemens†, Kari L. Deranian*, Michael Zhao*, Neil J. Hayward*, Jayhong A. Chong*, David Julius†‡, Magdalene M.

    Add to Reading List

    Source URL: www.hydrabiosciences.com

    Language: English - Date: 2008-03-25 13:59:59
    9Cubist Pharmaceuticals, Inc

    Cubist Pharmaceuticals, Inc

    Add to Reading List

    Source URL: www.hydrabiosciences.com

    Language: English - Date: 2012-01-10 11:13:58
    10Molecular Pain  BioMed Central Open Access

    Molecular Pain BioMed Central Open Access

    Add to Reading List

    Source URL: www.hydrabiosciences.com

    Language: English - Date: 2009-05-19 13:36:54